Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
8.625% Series A Cumulative, Perpetual Preferred Stock
Preferred Stock
8.375% Series B Cumulative, Perpetual Preferred Stock
Preferred Stock
Convertible preferred stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at beginning of period at Dec. 31, 2021 $ 49     $ 85 $ 1,307,030 $ (1,165,288) $ 141,876
Balance at beginning of period (in shares) at Dec. 31, 2021 984,000 2,000 5,000 11,315,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options       $ 1 632   633
Exercise of stock options (in shares)       91,000      
Issuance of common stock related to 401(k) contribution         85   85
Issuance of common stock related to 401(k) contribution (in shares)       4,000      
Stock-based compensation expense         978   978
Preferred stock dividends         (1,368)   (1,368)
Net loss and comprehensive loss           (2,280) (2,280)
Balance at end of period at Mar. 31, 2022 $ 49     $ 86 1,307,357 (1,167,568) 139,924
Balance at end of period (in shares) at Mar. 31, 2022 984,000 2,000 5,000 11,410,000      
Balance at beginning of period at Dec. 31, 2021 $ 49     $ 85 1,307,030 (1,165,288) 141,876
Balance at beginning of period (in shares) at Dec. 31, 2021 984,000 2,000 5,000 11,315,000      
Increase (Decrease) in Stockholders' Equity              
Net loss and comprehensive loss             (11,128)
Balance at end of period at Sep. 30, 2022 $ 49     $ 86 1,306,606 (1,176,416) 130,325
Balance at end of period (in shares) at Sep. 30, 2022 984,000 2,000 5,000 11,451,000      
Balance at beginning of period at Mar. 31, 2022 $ 49     $ 86 1,307,357 (1,167,568) 139,924
Balance at beginning of period (in shares) at Mar. 31, 2022 984,000 2,000 5,000 11,410,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options         189   189
Exercise of stock options (in shares)       11,000      
Issuance of common stock related to ESPP         45   45
Issuance of common stock related to ESPP (in shares)       3,000      
Stock-based compensation expense         836   836
Preferred stock dividends         (1,368)   (1,368)
Net loss and comprehensive loss           (4,670) (4,670)
Balance at end of period at Jun. 30, 2022 $ 49     $ 86 1,307,059 (1,172,238) 134,956
Balance at end of period (in shares) at Jun. 30, 2022 984,000 2,000 5,000 11,424,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options         109   109
Exercise of stock options (in shares)       27,000      
Stock-based compensation expense         806   806
Preferred stock dividends         (1,368)   (1,368)
Net loss and comprehensive loss           (4,178) (4,178)
Balance at end of period at Sep. 30, 2022 $ 49     $ 86 1,306,606 (1,176,416) 130,325
Balance at end of period (in shares) at Sep. 30, 2022 984,000 2,000 5,000 11,451,000      
Balance at beginning of period at Dec. 31, 2022 $ 49     $ 86 1,306,271 (1,182,392) 124,014
Balance at beginning of period (in shares) at Dec. 31, 2022 984,000 2,000 5,000 11,454,000      
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock related to 401(k) contribution         123   123
Issuance of common stock related to 401(k) contribution (in shares)       7,000      
Stock-based compensation expense         1,570   1,570
Preferred stock dividends         (1,368)   (1,368)
Net loss and comprehensive loss           (9,813) (9,813)
Balance at end of period at Mar. 31, 2023 $ 49     $ 86 1,306,596 (1,192,205) 114,526
Balance at end of period (in shares) at Mar. 31, 2023 984,000 2,000 5,000 11,461,000      
Balance at beginning of period at Dec. 31, 2022 $ 49     $ 86 1,306,271 (1,182,392) $ 124,014
Balance at beginning of period (in shares) at Dec. 31, 2022 984,000 2,000 5,000 11,454,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options (in shares)             8,473
Net loss and comprehensive loss             $ (20,722)
Balance at end of period at Sep. 30, 2023 $ 49     $ 86 1,308,943 (1,203,114) 105,964
Balance at end of period (in shares) at Sep. 30, 2023 984,000 2,000 5,000 11,472,000      
Balance at beginning of period at Mar. 31, 2023 $ 49     $ 86 1,306,596 (1,192,205) 114,526
Balance at beginning of period (in shares) at Mar. 31, 2023 984,000 2,000 5,000 11,461,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options         153   153
Exercise of stock options (in shares)       8,000      
Issuance of common stock related to ESPP         50   50
Issuance of common stock related to ESPP (in shares)       3,000      
Stock-based compensation expense         2,163   2,163
Preferred stock dividends         (1,368)   (1,368)
Net loss and comprehensive loss           (5,400) (5,400)
Balance at end of period at Jun. 30, 2023 $ 49     $ 86 1,307,594 (1,197,605) 110,124
Balance at end of period (in shares) at Jun. 30, 2023 984,000 2,000 5,000 11,472,000      
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense         2,717   2,717
Preferred stock dividends         (1,368)   (1,368)
Net loss and comprehensive loss           (5,509) (5,509)
Balance at end of period at Sep. 30, 2023 $ 49     $ 86 $ 1,308,943 $ (1,203,114) $ 105,964
Balance at end of period (in shares) at Sep. 30, 2023 984,000 2,000 5,000 11,472,000